Magnesium sulphate attenuates arterial blood pressure increase during laparoscopic cholecystectomy under pneumoperitoneum
Not Applicable
- Conditions
- Patients scheduled for elective laparoscopic cholecystectomy under CO2 pneumoperitoneum
- Registration Number
- JPRN-UMIN000001929
- Lead Sponsor
- Chunma medical research foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with following criteria 1. hypermagnesaemia 2. a known allergy to magnesium sulphate 3. any degree of heart block hypertension, diabetes mellitus, cardiovascular diseases or kidney dysfunction 4. acute cholecystitis 5. an endocrine or metabolic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemodynamic stability during intraoperative period
- Secondary Outcome Measures
Name Time Method neurohumoral responses in patients undergoing laparoscopic cholecystectomy